Repurposing Lenalidomide for Refractory Behcet’s Disease: Systematic Review and Computational Pharmacology Insights for Rare Disease Therapy

Chengzhen Lyu, Shuai Li, Kun He, Ziqi Guo, Rou Tang, Wangyang Chen, Weiyang Zheng, Dong Wu

Open source

DOI
10.2174/0115734099491715260903114308
Published
2026-09-10
Container
Current Computer-Aided Drug Design
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115734099491715260903114308,
  title = {Repurposing Lenalidomide for Refractory Behcet’s Disease: Systematic Review and Computational Pharmacology Insights for Rare Disease Therapy},
  author = {Chengzhen Lyu and Shuai Li and Kun He and Ziqi Guo and Rou Tang and Wangyang Chen and Weiyang Zheng and Dong Wu},
  year = {2026},
  journal = {Current Computer-Aided Drug Design},
  doi = {10.2174/0115734099491715260903114308},
  url = {https://doi.org/10.2174/0115734099491715260903114308}
}

RIS

TY  - JOUR
TI  - Repurposing Lenalidomide for Refractory Behcet’s Disease: Systematic Review and Computational Pharmacology Insights for Rare Disease Therapy
AU  - Chengzhen Lyu
AU  - Shuai Li
AU  - Kun He
AU  - Ziqi Guo
AU  - Rou Tang
AU  - Wangyang Chen
AU  - Weiyang Zheng
AU  - Dong Wu
PY  - 2026
JO  - Current Computer-Aided Drug Design
DO  - 10.2174/0115734099491715260903114308
UR  - https://doi.org/10.2174/0115734099491715260903114308
ER  - 

APA

Lyu, C., Li, S., He, K., Guo, Z., Tang, R., Chen, W., Zheng, W., & Wu, D. (2026). Repurposing Lenalidomide for Refractory Behcet’s Disease: Systematic Review and Computational Pharmacology Insights for Rare Disease Therapy. Current Computer-Aided Drug Design. https://doi.org/10.2174/0115734099491715260903114308

Source records